Paola Queirolo

6PUBLICATIONS
102CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsTumour immunologyPredictive and prognostic markersGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 21, 2025
Evaluation of Sonidegib Cytoreductive Activity in Locally Advanced Basal Cell Carcinoma Treatment: A Delphi Consensus.

Paolo Antonio Ascierto, Maria Concetta Fargnoli, Corrado Caracò

|May 01, 2023
Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer.

Alessio Cortellini, Antonio D'Alessio, Siobhan Cleary

|Apr 14, 2023
Adjuvant Nivolumab versus Ipilimumab in Resected Stage III/IV Melanoma: 5-Year Efficacy and Biomarker Results from CheckMate 238.

James Larkin, Michele Del Vecchio, Mario Mandalá

|Jan 21, 2022
The Multidisciplinary Management of Cutaneous Squamous Cell Carcinoma: A Comprehensive Review and Clinical Recommendations by a Panel of Experts.

Ignazio Stanganelli, Francesco Spagnolo, Giuseppe Argenziano

|Dec 10, 2021
Clinical Significance of Distant Metastasis-Free Survival (DMFS) in Melanoma: A Narrative Review from Adjuvant Clinical Trials.

Simone Amabile, Gabriele Roccuzzo, Valentina Pala

|Dec 28, 2020
KEYNOTE-022 part 3: a randomized, double-blind, phase 2 study of pembrolizumab, dabrafenib, and trametinib in BRAF-mutant melanoma.

Pier Francesco Ferrucci, Anna Maria Di Giacomo, Michele Del Vecchio

Pageof 1

Frequent Collaborators

5 joint publications

Paolo Antonio Ascierto

2 joint publications

Mario Mandalá

1 joint publications

Pier Francesco Ferrucci

1 joint publications

Georgina V Long